These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K, Chandler P, Altmann DM. Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820 [Abstract] [Full Text] [Related]
7. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. Myers KJ, Dougherty JP, Ron Y. J Immunol; 1993 Aug 15; 151(4):2252-60. PubMed ID: 7688395 [Abstract] [Full Text] [Related]
8. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein. Mannie MD, Paterson PY, U'Prichard DC, Flouret G. J Immunol; 1989 Apr 15; 142(8):2608-16. PubMed ID: 2467932 [Abstract] [Full Text] [Related]
12. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. Whitham RH, Jones RE, Hashim GA, Hoy CM, Wang RY, Vandenbark AA, Offner H. J Immunol; 1991 Dec 01; 147(11):3803-8. PubMed ID: 1719089 [Abstract] [Full Text] [Related]
14. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Lab Invest; 1997 Mar 01; 76(3):355-64. PubMed ID: 9121118 [Abstract] [Full Text] [Related]